All stock lists
Telefonica Brasil S.A. (New York Stock Exchange:VIV)
BR · Delayed Price · Currency is USD
Communication Services · Telecommunications Services
11.59-0.03 (-0.22%)
Market cap
$18.5B
Insider Score
Health Score
Analyst consensus
Listed since
Nov 16, 1998
Website
Insider Score
––Not scored
VIV Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
VIV analyst forecast
VIV analyst consensus
Hold1 ratings
Buy 0 Hold 1 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
VIV 12-month price target
No published price targets in the last 12 months.
VIV ratings mix, last 12 months
Buy Hold Sell
Best analysts covering VIV
No firm covering VIV has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
VIV analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-10-29 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-07-16 |
| — | Scotiabank | Sector Perform | — | — | Reiterated | 2026-05-27 |
| — | Scotiabank | Sector Perform | — | — | Reiterated | 2026-05-12 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-04-17 |
| — | Scotiabank | Sector Perform | — | — | Reiterated | 2026-03-30 |
| — | Barclays | Equal Weight | — | — | Downgraded | 2026-03-12 |
| — | UBS | Sell | — | — | Downgraded | 2026-03-11 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2025-08-19 |
| — | JP Morgan | Underweight | — | — | Downgraded | 2025-08-08 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-08-07 |
| — | Scotiabank | Sector Perform | — | — | Reiterated | 2025-07-31 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-07-14 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2025-04-30 |
| — | Barclays | Overweight | — | — | Upgraded | 2025-03-03 |
| — | Scotiabank | Sector Perform | — | — | Reiterated | 2025-02-27 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2024-12-19 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2024-11-25 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2024-08-01 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2024-05-09 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2024-04-23 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2024-02-26 |
| — | Morgan Stanley | Equal Weight | — | — | Downgraded | 2024-01-05 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2023-12-07 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2023-08-02 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2023-05-31 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2023-05-12 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2022-12-22 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2022-08-09 |
| — | Scotiabank | Sector Perform | — | — | Downgraded | 2022-04-07 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2021-11-02 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2021-10-07 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2021-08-09 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2021-05-19 |
| — | ScotiaBank | Outperform | — | — | Reiterated | 2020-07-30 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2020-05-11 |
| — | Goldman Sachs | Buy | — | — | Upgraded | 2020-04-02 |
| — | Barclays | Equal Weight | — | — | Downgraded | 2019-08-01 |
| — | Barclays | Overweight | — | — | Reiterated | 2019-05-14 |
| — | Barclays | Overweight | — | — | Reiterated | 2018-11-01 |
| — | Barclays | Overweight | — | — | Reiterated | 2018-10-22 |
| — | Barclays | Overweight | — | — | Reiterated | 2018-07-11 |
| — | Morgan Stanley | Overweight | — | — | Upgraded | 2018-06-13 |
| — | Barclays | Overweight | — | — | Reiterated | 2018-04-26 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2018-04-03 |
| — | Barclays | Overweight | — | — | Reiterated | 2018-03-20 |
| — | Barclays | Overweight | — | — | Reiterated | 2017-10-26 |
| — | Barclays | Overweight | — | — | Reiterated | 2017-10-16 |
| — | Barclays | Overweight | — | — | Reiterated | 2016-07-28 |
| — | Morgan Stanley | Equal Weight | — | — | Downgraded | 2016-07-06 |
| — | Barclays | Overweight | — | — | Reiterated | 2016-04-01 |
| — | Barclays | Overweight | — | — | Reiterated | 2015-10-06 |
| — | Morgan Stanley | Overweight | — | — | Upgraded | 2015-08-31 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2014-05-09 |
| — | Standpoint Research | Buy | — | — | Reiterated | 2014-03-03 |
| — | Goldman Sachs | Neutral | — | — | Downgraded | 2013-11-14 |
| — | Credit Suisse | Neutral | — | — | Downgraded | 2013-10-07 |
| — | Citigroup | Sell | — | — | Reiterated | 2013-08-07 |
| — | Bank of America | Buy | — | — | Upgraded | 2013-02-26 |
| — | Barclays | Overweight | — | — | Reiterated | 2012-10-04 |
VIV earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2025-10-30 | 0.19 | 0.22 | $2.88B | $2.80B |
| 2026-02-23 | 0.17 | 0.22 | $2.93B | $3.03B |
| 2026-05-11 | 0.17 | 0.15 | $2.99B | $3.16B |
| 2026-07-27 | 0.23 | 0.19 | $3.04B | $3.08B |
| 2026-11-10Upcoming | 0.24 | — | $3.10B | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.